David Cella

148.6k total citations · 38 hit papers
1.3k papers, 95.1k citations indexed

About

David Cella is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, David Cella has authored 1.3k papers receiving a total of 95.1k indexed citations (citations by other indexed papers that have themselves been cited), including 527 papers in Oncology, 277 papers in Pulmonary and Respiratory Medicine and 265 papers in Economics and Econometrics. Recurrent topics in David Cella's work include Cancer survivorship and care (351 papers), Childhood Cancer Survivors' Quality of Life (209 papers) and Health Systems, Economic Evaluations, Quality of Life (202 papers). David Cella is often cited by papers focused on Cancer survivorship and care (351 papers), Childhood Cancer Survivors' Quality of Life (209 papers) and Health Systems, Economic Evaluations, Quality of Life (202 papers). David Cella collaborates with scholars based in United States, United Kingdom and Canada. David Cella's co-authors include Ron D. Hays, Dennis A. Revicki, Jin‐Shei Lai, Kimberly Webster, David S. Tulsky, S B Yellen, Amy H. Peterman, Amy E. Bonomi, Seung W. Choi and Karon F. Cook and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

David Cella

1.3k papers receiving 92.5k citations

Hit Papers

The Functional Assessment of Cancer Therapy scale: develo... 1993 2026 2004 2015 1993 2007 2007 2003 2007 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.
    1993 4.7k citations David Cella, David S. Tulsky et al. Journal of Clinical Oncology profile →
  2. The Patient-Reported Outcomes Measurement Information System (PROMIS)
    2007 2.4k citations David Cella, Richard Gershon et al. Medical Care profile →
  3. Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
    2007 2.3k citations David Cella et al. profile →
  4. Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
    2003 2.1k citations David Cella et al. profile →
  5. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes
    2007 1.7k citations Dennis A. Revicki, Ron D. Hays et al. Journal of Clinical Epidemiology profile →
  6. Item Banks for Measuring Emotional Distress From the Patient-Reported Outcomes Measurement Information System (PROMIS®): Depression, Anxiety, and Anger
    2011 1.6k citations Seung W. Choi, Steven P. Reise et al. profile →
  7. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system
    1997 1.5k citations David Cella et al. profile →
  8. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.
    1997 1.5k citations David Cella, David S. Tulsky et al. Journal of Clinical Oncology profile →
  9. Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items
    2009 1.4k citations Ron D. Hays, Jakob Bue Bjørner et al. Quality of Life Research profile →
  10. Measuring spiritual well-being in people with cancer: The functional assessment of chronic illness therapy—spiritual well-being scale (FACIT-Sp)
    2002 1.3k citations David Cella et al. profile →
  11. Psychometric Evaluation and Calibration of Health-Related Quality of Life Item Banks
    2007 1.2k citations Bryce B. Reeve, Ron D. Hays et al. Medical Care profile →
  12. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation.
    2003 1.2k citations David Cella et al. Health and Quality of Life Outcomes profile →
  13. Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition
    2000 979 citations David Cella et al. profile →
  14. Development of a PROMIS item bank to measure pain interference
    2010 869 citations Karon F. Cook, Dennis A. Revicki et al. profile →
  15. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial
    2005 852 citations David Cella et al. profile →
  16. Combining Anchor and Distribution-Based Methods to Derive Minimal Clinically Important Differences on the Functional Assessment of Cancer Therapy (FACT) Anemia and Fatigue Scales
    2002 652 citations David Cella, Jin‐Shei Lai et al. profile →
  17. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
    2007 640 citations A. Simon Pickard, Maureen P. Neary et al. Health and Quality of Life Outcomes profile →
  18. Fatigue in cancer patients compared with fatigue in the general United States population
    2002 638 citations David Cella, Jin‐Shei Lai et al. profile →
  19. A case for including spirituality in quality of life measurement in oncology
    1999 632 citations David Cella et al. profile →
  20. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition.
    1997 625 citations David Cella et al. profile →
  21. Reliability and validity of the functional assessment of cancer therapy—lung (FACT-L) quality of life instrument
    1995 620 citations David Cella, David S. Tulsky et al. profile →
  22. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.
    1998 606 citations David Cella et al. Journal of Clinical Oncology profile →
  23. Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial
    2011 604 citations David Cella et al. Journal of Clinical Oncology profile →
  24. Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)
    2016 585 citations David Cella et al. profile →
  25. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue.
    1997 574 citations David Cella profile →
  26. A Comprehensive Method for the Translation and Cross-Cultural Validation of Health Status Questionnaires
    2005 518 citations David Cella et al. profile →
  27. Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients
    2011 502 citations David Cella et al. Journal of Clinical Epidemiology profile →
  28. Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study
    2009 497 citations David Cella et al. Journal of Clinical Oncology profile →
  29. Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
    2004 479 citations David Cella et al. Journal of Clinical Oncology profile →
  30. The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale: A study of utility and validity
    1996 448 citations David Cella et al. profile →
  31. The development of a financial toxicity patient‐reported outcome in cancer: The COST measure
    2014 445 citations David Cella et al. profile →
  32. PROMIS® Adult Health Profiles: Efficient Short-Form Measures of Seven Health Domains
    2019 424 citations David Cella, Seung W. Choi et al. profile →
  33. PROMIS®-29 v2.0 profile physical and mental health summary scores
    2018 409 citations Ron D. Hays, Benjamin D. Schalet et al. Quality of Life Research profile →
  34. Representativeness of the Patient-Reported Outcomes Measurement Information System Internet panel
    2010 373 citations Honghu Liu, David Cella et al. Journal of Clinical Epidemiology profile →
  35. Establishing a common metric for depressive symptoms: Linking the BDI-II, CES-D, and PHQ-9 to PROMIS Depression.
    2014 366 citations Seung W. Choi, Benjamin D. Schalet et al. profile →
  36. Clinical validity of PROMIS Depression, Anxiety, and Anger across diverse clinical samples
    2016 358 citations Benjamin D. Schalet, William T. Riley et al. Journal of Clinical Epidemiology profile →
  37. PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions
    2016 345 citations Karon F. Cook, Benjamin D. Schalet et al. Journal of Clinical Epidemiology profile →
  38. Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measures
    2021 283 citations Caroline B. Terwee, Jin‐Shei Lai et al. Quality of Life Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Cella United States 151 37.1k 18.5k 15.4k 11.9k 9.7k 1.3k 95.1k
Neil K. Aaronson Netherlands 105 17.8k 0.5× 9.6k 0.5× 6.6k 0.4× 6.5k 0.5× 8.0k 0.8× 463 47.4k
Graham A. Colditz United States 210 33.5k 0.9× 11.3k 0.6× 9.3k 0.6× 49.0k 4.1× 13.7k 1.4× 1.4k 167.0k
Stuart Pocock United Kingdom 117 9.7k 0.3× 16.7k 0.9× 6.9k 0.5× 14.4k 1.2× 32.9k 3.4× 582 143.9k
Jan P. Vandenbroucke Netherlands 93 9.1k 0.2× 12.6k 0.7× 7.4k 0.5× 14.5k 1.2× 21.8k 2.2× 439 111.3k
Erik von Elm Switzerland 43 7.8k 0.2× 10.4k 0.6× 6.2k 0.4× 12.9k 1.1× 18.6k 1.9× 131 89.7k
Andrew D Oxman Norway 93 6.4k 0.2× 11.7k 0.6× 7.6k 0.5× 18.1k 1.5× 18.6k 1.9× 300 107.1k
Jonathan J Deeks United Kingdom 92 8.3k 0.2× 11.8k 0.6× 5.8k 0.4× 9.1k 0.8× 20.0k 2.1× 368 96.6k
Kenneth F. Schulz United States 79 5.7k 0.2× 8.9k 0.5× 7.2k 0.5× 16.6k 1.4× 17.3k 1.8× 216 102.7k
Henrik Toft Sørensen Denmark 119 8.6k 0.2× 9.5k 0.5× 6.9k 0.4× 9.4k 0.8× 16.9k 1.7× 1.6k 77.7k
Holger J. Schünemann Canada 118 5.6k 0.2× 11.5k 0.6× 4.8k 0.3× 15.5k 1.3× 15.6k 1.6× 712 87.8k

Countries citing papers authored by David Cella

Since Specialization
Citations

This map shows the geographic impact of David Cella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Cella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Cella more than expected).

Fields of papers citing papers by David Cella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Cella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Cella. The network helps show where David Cella may publish in the future.

Co-authorship network of co-authors of David Cella

This figure shows the co-authorship network connecting the top 25 collaborators of David Cella. A scholar is included among the top collaborators of David Cella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Cella. David Cella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Röth, Alexander, Catherine M. Broome, Wilma Barcellini, et al.. (2023). Long-term sutimlimab improves quality of life for patients with cold agglutinin disease: CARDINAL 2-year follow-up. Blood Advances. 7(19). 5890–5897. 8 indexed citations
3.
Khan, Sadiya S., Abigail S. Baldridge, Kathleen L. Grady, et al.. (2023). Health Status in Heart Failure and Cancer. JACC Heart Failure. 12(7). 1166–1178. 4 indexed citations
4.
Arrarás, Juan Ignacio, Mogens Grøenvold, Bernhard Holzner, et al.. (2023). Equipercentile equating of scores from common patient-reported outcome measures of physical function in patients with cancer. Journal of Clinical Epidemiology. 165. 111203–111203. 7 indexed citations
5.
Schalet, Benjamin D., et al.. (2021). Linking Scores with Patient-Reported Health Outcome Instruments: A Validation Study and Comparison of Three Linking Methods. Psychometrika. 86(3). 717–746. 41 indexed citations
6.
Flynn, Kathryn E., Sarah Mansfield, Abigail R. Smith, et al.. (2020). Patient demographic and psychosocial characteristics associated with 30‐day recall of self‐reported lower urinary tract symptoms. Neurourology and Urodynamics. 39(7). 1939–1948. 6 indexed citations
7.
Kisala, Pamela A., Aaron J. Boulton, Matthew L. Cohen, et al.. (2019). Interviewer- versus self-administration of PROMIS® measures for adults with traumatic injury.. Health Psychology. 38(5). 435–444. 31 indexed citations
8.
Shilling, Valerie, et al.. (2018). Development and validation of the patient roles and responsibilities scale in cancer patients. Quality of Life Research. 27(11). 2923–2934. 9 indexed citations
9.
Nowinski, Cindy J., Deborah Miller, & David Cella. (2017). Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials. Neurotherapeutics. 14(4). 934–944. 49 indexed citations
10.
Jensen, Roxanne E., Arnold L. Potosky, Carol M. Moinpour, et al.. (2017). United States Population-Based Estimates of Patient-Reported Outcomes Measurement Information System Symptom and Functional Status Reference Values for Individuals With Cancer. Journal of Clinical Oncology. 35(17). 1913–1920. 144 indexed citations
11.
Crins, Martine, Leo D. Roorda, Niels Smits, et al.. (2015). Calibration and Validation of the Dutch-Flemish PROMIS Pain Interference Item Bank in Patients with Chronic Pain. PLoS ONE. 10(7). e0134094–e0134094. 36 indexed citations
12.
Chiu, Leonard, Nicholas Chiu, Edward Chow, et al.. (2014). Comparison of Three Shortened Questionnaires for Assessment of Quality of Life in Advanced Cancer. Journal of Palliative Medicine. 17(8). 918–923. 18 indexed citations
13.
Tucker, Carole A., Alarcos Cieza, Anne W. Riley, et al.. (2014). Concept Analysis of the Patient Reported Outcomes Measurement Information System (PROMIS®) and the International Classification of Functioning, Disability and Health (ICF). Quality of Life Research. 23(6). 1677–1686. 44 indexed citations
14.
Alonso, Jordi, Susan J. Bartlett, Matthias Rose, et al.. (2013). The case for an international patient-reported outcomes measurement information system (PROMIS®) initiative. Health and Quality of Life Outcomes. 11(1). 210–210. 126 indexed citations
15.
Escudier, Bernard, Cezary Szczylik, Thomas E. Hutson, et al.. (2009). Randomized Phase II Trial of First-Line Treatment With Sorafenib Versus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma. Journal of Clinical Oncology. 27(8). 1280–1289. 378 indexed citations
16.
Kornblith, Alice B., Helen Huang, Joan L. Walker, et al.. (2009). Quality of Life of Patients With Endometrial Cancer Undergoing Laparoscopic International Federation of Gynecology and Obstetrics Staging Compared With Laparotomy: A Gynecologic Oncology Group Study. Journal of Clinical Oncology. 27(32). 5337–5342. 213 indexed citations
17.
Reeve, Bryce B., Ron D. Hays, Jakob Bue Bjørner, et al.. (2007). Psychometric Evaluation and Calibration of Health-Related Quality of Life Item Banks. Medical Care. 45(5). S22–S31. 1211 indexed citations breakdown →
18.
Gershenson, David M., Anna M. Miller, Victoria L. Champion, et al.. (2007). Reproductive and Sexual Function After Platinum-Based Chemotherapy in Long-Term Ovarian Germ Cell Tumor Survivors: A Gynecologic Oncology Group Study. Journal of Clinical Oncology. 25(19). 2792–2797. 127 indexed citations
19.
Pickard, A. Simon, Maureen P. Neary, & David Cella. (2007). Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health and Quality of Life Outcomes. 5(1). 70–70. 640 indexed citations breakdown →
20.
Cella, David. (1995). Functional Assessment of Cancer Therapy - Lung (FACT-L). Patient Preference and Adherence. 7. 133–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neil K. Aaronson Breakdown of academic impact, for papers by Graham A. Colditz Breakdown of academic impact, for papers by Stuart Pocock Breakdown of academic impact, for papers by Jan P. Vandenbroucke Breakdown of academic impact, for papers by Erik von Elm Breakdown of academic impact, for papers by Andrew D Oxman Breakdown of academic impact, for papers by Jonathan J Deeks Breakdown of academic impact, for papers by Kenneth F. Schulz Breakdown of academic impact, for papers by Henrik Toft Sørensen Breakdown of academic impact, for papers by Holger J. Schünemann
Rankless by CCL
2026